HomeAI · summaries
Storia in 7 fonti
Experts evaluate promising Ebola treatments, including vax candidate from Oxford/Serum Institute
Advisory groups convened by the World Health Organization have considered promising candidates for prioritisation and evaluation in clinical trials, including a candidate vaccine ChAdOx1 Bundibugyo being developed by Oxford University/Serum Institute of India. The vaccine could potentially become available within two to three months for efficacy assessment through a clinical trial, said the WHO
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 months
A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. Researchers at Oxford University are…
- ·
businessday.ng
Ebola vaccine from Oxford Covid team nears production for trials - Businessday NG
Production of an experimental Ebola vaccine from the developers of a Covid-19 shot is expected to begin soon, with animal studies...
- ·
arabnews.com
WHO experts want trials on potential Ebola vaccines, treatments
GENEVA: The World Health Organization said Thursday its advisory groups had recommended clinical trials for vaccines and treatments that could be useful against the Bundibugyo…
- ·
thecitizen.co.tz
WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak
The WHO advisors also recommended evaluating combination therapy using a monoclonal antibody together with remdesivir.
- ·
lasicilia.it
Ebola, l’Oms individua vaccini e terapie promettenti: le sperimentazioni richiederanno mesi
Da mettere in campo contro l’epidemia di ebola da ceppo Bundibugyo nella Repubblica Democratica del Congo
- ·
thehindubusinessline.com
Experts evaluate promising Ebola treatments, including vax candidate from Oxford/Serum Institute
Advisory groups convened by the World Health Organization have considered promising candidates for prioritisation and evaluation in clinical trials, including a candidate vaccine…
- ·
standardmedia.co.ke
WHO recommends trial use of two vaccines as virus spreads
WHO recommends two Ebola vaccine candidates for trials as Bundibugyo outbreak spreads in DRC and Uganda with no approved treatment yet.